Who Paid My Doc
Michelle Billings Williams
Preventive Medicine/Occupational Environmental Medicine Vero Beach, FL Nurse Practitioner
NPI 1114469350 CMS profile 10782764
960 37Th Pl Ste 101, Vero Beach, FL 32960
General payments
$1,024
Research payments
$0
Ownership & investment interest
$0
Through program year 2024, Michelle Billings Williams of Vero Beach, FL is reported in the CMS Open Payments database as having received $1,024 across 57 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 85th percentile of Preventive Medicine/Occupational Environmental Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
4 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $15 | 1 | |
| 2023 | General | $93 | 5 | |
| 2022 | General | $39 | 2 | |
| 2021 | General | $877 | 49 |
Beside peers
- Michelle Billings Williams
- Preventive Medicine/Occupational Environmental Medicine median
- Middle half of Preventive Medicine/Occupational Environmental Medicine
- National median
In program year 2025, general payments to Michelle Billings Williams were reported at $0. Among 86 Preventive Medicine/Occupational Environmental Medicine profiles paid that year, the median was $76 and the middle half received between $25 and $241.
Show as a table
| Year | Michelle Billings Williams | Preventive Medicine/Occupational Environmental Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $74 | $23–$125 | $163 |
| 2020 | $0 | $50 | $22–$170 | $114 |
| 2021 | $877 | $48 | $19–$228 | $132 |
| 2022 | $39 | $51 | $21–$156 | $149 |
| 2023 | $93 | $55 | $26–$205 | $160 |
| 2024 | $15 | $67 | $24–$237 | $164 |
| 2025 | $0 | $76 | $25–$241 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 23 drugsPart D claims
473
Drug cost
$4,346
Branded share of claims
6.6%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | Brand | 31 | $765 | |
| Telmisartan | Generic | 11 | $596 | |
| Gabapentin | Generic | 25 | $436 | |
| Fluticasone Propionate | Generic | 26 | $327 | |
| Metformin Hcl | Generic | 45 | $193 | |
| Atorvastatin Calcium | Generic | 26 | $175 | |
| Levothyroxine Sodium | Generic | 15 | $173 | |
| Losartan Potassium | Generic | 27 | $172 | |
| Amlodipine Besylate | Generic | 35 | $167 | |
| Sumatriptan Succinate | Generic | 12 | $164 |
The 10 drugs with the highest cost, of 23 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.
Payments and prescribing
1 product · payments 2024Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.
| Product | Paid by | Related payments | Part D claims | Part B services |
|---|---|---|---|---|
| VRAYLAR |
|
$15 | — | — |
A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.
Records
57 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Preventive Medicine/Occupational Environmental Medicine in Florida
Sheri Prentiss
Preventive Medicine/Occupational Environmental Medicine · Pompano Beach, FL
Dwayne Wilson
Preventive Medicine/Occupational Environmental Medicine · Tampa, FL
Rachel Williams
Preventive Medicine/Occupational Environmental Medicine · Tampa, FL
Joseph Mignogna
Preventive Medicine/Occupational Environmental Medicine · Cape Canaveral, FL
Eve Hanna
Preventive Medicine/Occupational Environmental Medicine · Tampa, FL
Laurie Kardon
Preventive Medicine/Occupational Environmental Medicine · West Palm Beach, FL
Related records
Preventive Medicine/Occupational Environmental Medicine in Florida
Practitioners in the same specialty and state, ranked by reported value.
All Preventive Medicine/Occupational Environmental Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Florida
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.